PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $184,000 | -70.5% | 58,463 | -72.8% | 0.00% | – |
| Q2 2020 | $624,000 | +543.3% | 214,559 | +375.7% | 0.00% | – |
| Q3 2019 | $97,000 | -53.6% | 45,103 | -32.3% | 0.00% | – |
| Q2 2019 | $209,000 | +31.4% | 66,664 | +56.4% | 0.00% | – |
| Q1 2019 | $159,000 | +160.7% | 42,635 | +103.8% | 0.00% | – |
| Q4 2018 | $61,000 | -9.0% | 20,917 | -17.8% | 0.00% | – |
| Q3 2018 | $67,000 | -14.1% | 25,434 | -4.6% | 0.00% | – |
| Q1 2018 | $78,000 | -45.1% | 26,652 | -48.7% | 0.00% | – |
| Q4 2017 | $142,000 | +208.7% | 51,972 | +279.1% | 0.00% | – |
| Q1 2016 | $46,000 | -80.7% | 13,709 | -71.1% | 0.00% | -100.0% |
| Q3 2015 | $238,000 | +36.0% | 47,409 | +90.6% | 0.00% | 0.0% |
| Q1 2015 | $175,000 | -23.9% | 24,875 | -16.5% | 0.00% | -50.0% |
| Q4 2014 | $230,000 | -58.4% | 29,804 | -59.7% | 0.00% | -66.7% |
| Q3 2014 | $553,000 | +453.0% | 74,031 | +512.5% | 0.01% | +500.0% |
| Q1 2014 | $100,000 | – | 12,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |